Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) is a publicly traded Healthcare sector company. As of November 19, 2026, SCNI trades at $0.34 with a market cap of $1.06M and a P/E ratio of 0.00. SCNI moved -11.41% today. Year to date, SCNI is -95.03%; over the trailing twelve months it is -96.12%. Its 52-week range spans $0.35 to $61.80. Rallies surfaces SCNI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Scinai expects operating runway through late 2027: Scinai Immunotherapeutics expects its operating runway to extend through late 2027, supported by approximately $5.3 million in recent net financing proceeds and expected customer payments. Activating later CDMO project phases could extend runway into the third quarter of 2028, subject to sales, collections and execution.
| Metric | Value |
|---|---|
| Price | $0.34 |
| Market Cap | $1.06M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $61.80 |
| 52-Week Low | $0.35 |
| Volume | 8.35M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
SCNI analyst coverage data. Average price target: $0.00.